NCT06270277

Brief Summary

Inflammatory bowel disease (IBD) is a chronic condition that affects the psychosocial status and physical activities of children and their parents in many ways. Our study aimed to investigate the variability of disease-related quality of life and behavioral and emotional adjustment issues compared to a healthy control group among adolescents and their families diagnosed with IBD. Children with IBD and the healthy control group, as well as the parents of both groups, will administered the Pediatric Quality of Life Inventory (PedsQL) and Strengths and Difficulties Questionnaire (SDQ). The PedsQL is a scale used to assess physical and psychosocial functioning based on the individual's own experiences, commonly employed in clinical trials and quality improvement initiatives. The scale evaluates physical activity status and psychosocial functioning through questions related to emotional, social, and school-related issues.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
159

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 13, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

February 14, 2024

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 21, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 21, 2024

Completed
Last Updated

February 22, 2024

Status Verified

February 1, 2024

Enrollment Period

6 days

First QC Date

February 13, 2024

Last Update Submit

February 21, 2024

Conditions

Keywords

Inflammatory bowel diseasesPsychosocial conditionCrohn's diseaseUlcerative colitis

Outcome Measures

Primary Outcomes (2)

  • Pediatric Quality of Life Inventory (PedsQL) score

    Score of questionnaire

    1 day after questionnaire

  • Strengths and Difficulties Questionnaire (SDQ)

    Score of questionnaire

    1 day after questionnaire

Study Arms (2)

Inflammatory bowel disease group

EXPERIMENTAL

Adolescents with Inflammatory bowel diseases will be administered Pediatric Quality of Life Inventory (PedsQL) and Strengths and Difficulties Questionnaire (SDQ).

Diagnostic Test: Pediatric Quality of Life Inventory (PedsQL)Diagnostic Test: Strengths and Difficulties Questionnaire (SDQ)

Control group

ACTIVE COMPARATOR

Adolescents without known diseases in same age group will be administered Pediatric Quality of Life Inventory (PedsQL) and Strengths and Difficulties Questionnaire (SDQ) as control group

Diagnostic Test: Pediatric Quality of Life Inventory (PedsQL)Diagnostic Test: Strengths and Difficulties Questionnaire (SDQ)

Interventions

Questionnaire

Control groupInflammatory bowel disease group

Questionnaire

Control groupInflammatory bowel disease group

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Aged between 8-17 years
  • Diagnosed Inflammatory bowel disease
  • Healthy adolescents aged between 8-17 years

You may not qualify if:

  • Not obtaining informed consent
  • Diagnosis of psychiatric disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sisli Hamidiye Etfal Research and Training Hospital

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Inflammatory Bowel DiseasesCrohn DiseaseColitis, Ulcerative

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesColitisColonic Diseases

Study Officials

  • Nafiye Urgancı, M.D.

    Sisli Hamidiye Etfal Training and Research Hospital, Division of pediatric gastroenterology

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Adolescents with Inflammatory bowel diseases and healthy control group in same age will be administered Pediatric Quality of Life Inventory (PedsQL) and Strengths and Difficulties Questionnaire (SDQ).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

February 13, 2024

First Posted

February 21, 2024

Study Start

February 14, 2024

Primary Completion

February 20, 2024

Study Completion

February 21, 2024

Last Updated

February 22, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations